Watchlist Manager

Watchlist

Price: 57 600 KRW -1.87% Market Closed

Market Cap: ₩2.6T

C	Celltrion Pharm Inc KOSDAQ:068760	KR
	SMS Alternatives Inc OTC:CICN	US
S	Southern Rubber Industry JSC VN:CSM	VN
	Starbucks Corp NASDAQ:SBUX	US

Income Statement

Currency: KRW

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	45	46	47	41	29	0	0	0	0	0	0	0	2	5	12	14	13	13	6	19	20	0	0	0	412	0	0	0	712	118	0	0	887	0	0	0	1 444	1 660	2 524	3 539	3 076	3 047	4 084	4 650	8 733	10 086	9 501	9 201	8 459	7 419	7 630	7 746	5 475	5 721	5 658	5 833	5 965	5 972	5 798	5 481	5 244	5 042	4 875	4 696	4 583	4 645	4 848	5 133	5 358	5 528	5 678	5 909	6 217	6 821	7 443	7 848	8 290	8 129	7 869	7 795	7 506	7 392	7 294	6 969
Revenue	16 588 N/A	17 415 +5%	17 872 +3%	18 995 +6%	20 645 +9%	22 272 +8%	22 389 +1%	22 037 -2%	22 744 +3%	21 431 -6%	20 673 -4%	18 686 -10%	19 608 +5%	22 619 +15%	24 015 +6%	23 908 0%	16 795 -30%	8 978 -47%	3 426 -62%	5 982 +75%	15 453 +158%	23 657 +53%	32 964 +39%	37 607 +14%	41 825 +11%	42 570 +2%	43 721 +3%	43 965 +1%	46 494 +6%	47 063 +1%	48 157 +2%	49 257 +2%	46 968 -5%	50 372 +7%	51 379 +2%	52 591 +2%	52 657 +0%	51 795 -2%	57 363 +11%	64 916 +13%	66 744 +3%	70 635 +6%	72 004 +2%	71 141 -1%	74 732 +5%	76 610 +3%	82 941 +8%	85 560 +3%	104 811 +23%	109 022 +4%	116 961 +7%	129 330 +11%	135 860 +5%	141 016 +4%	141 468 +0%	141 713 +0%	146 880 +4%	158 150 +8%	166 472 +5%	179 170 +8%	173 513 -3%	179 313 +3%	183 085 +2%	201 141 +10%	233 568 +16%	274 730 +18%	327 081 +19%	352 489 +8%	398 738 +13%	401 943 +1%	408 590 +2%	421 485 +3%	386 040 -8%	387 294 +0%	392 147 +1%	381 737 -3%	388 794 +2%	395 752 +2%	402 662 +2%	437 408 +9%	477 835 +9%	493 391 +3%	507 534 +3%	517 578 +2%
Gross Profit
Cost of Revenue	(10 009)	(10 255)	(10 333)	(10 462)	(11 646)	(12 458)	(12 533)	(12 449)	(11 405)	(10 591)	(10 245)	(9 521)	(12 992)	(17 914)	(20 961)	(22 126)	(15 925)	(8 539)	(3 158)	(2 024)	(5 507)	(7 827)	(10 778)	(12 084)	(13 516)	(13 713)	(13 883)	(13 839)	(14 823)	(15 568)	(15 970)	(16 436)	(15 166)	(16 262)	(16 833)	(17 053)	(17 084)	(17 200)	(19 153)	(22 547)	(23 495)	(24 167)	(24 756)	(24 599)	(26 841)	(28 289)	(33 798)	(36 060)	(52 639)	(59 751)	(63 916)	(73 411)	(77 575)	(81 365)	(90 037)	(98 185)	(106 291)	(115 558)	(117 205)	(121 852)	(111 046)	(111 838)	(114 764)	(131 149)	(160 404)	(193 658)	(229 885)	(242 787)	(279 485)	(282 063)	(292 548)	(301 475)	(273 266)	(271 898)	(270 116)	(264 228)	(269 084)	(280 040)	(293 061)	(323 100)	(355 824)	(361 925)	(364 862)	(366 443)
Gross Profit	6 579 N/A	7 161 +9%	7 539 +5%	8 533 +13%	8 999 +5%	9 814 +9%	9 856 +0%	9 588 -3%	11 340 +18%	10 840 -4%	10 428 -4%	9 165 -12%	6 616 -28%	4 705 -29%	3 054 -35%	1 782 -42%	870 -51%	420 -52%	267 -36%	3 958 +1 382%	9 946 +151%	15 829 +59%	22 186 +40%	25 523 +15%	28 309 +11%	28 857 +2%	29 838 +3%	30 126 +1%	31 671 +5%	31 494 -1%	32 185 +2%	32 819 +2%	31 801 -3%	34 109 +7%	34 546 +1%	35 538 +3%	35 573 +0%	34 595 -3%	38 211 +10%	42 370 +11%	43 249 +2%	46 470 +7%	47 249 +2%	46 543 -1%	47 892 +3%	48 321 +1%	49 143 +2%	49 499 +1%	52 172 +5%	49 269 -6%	53 043 +8%	55 918 +5%	58 286 +4%	59 651 +2%	51 431 -14%	43 528 -15%	40 589 -7%	42 592 +5%	49 267 +16%	57 318 +16%	62 467 +9%	67 475 +8%	68 321 +1%	69 992 +2%	73 164 +5%	81 072 +11%	97 197 +20%	109 702 +13%	119 253 +9%	119 881 +1%	116 042 -3%	120 011 +3%	112 774 -6%	115 396 +2%	122 031 +6%	117 509 -4%	119 710 +2%	115 713 -3%	109 602 -5%	114 308 +4%	122 011 +7%	131 466 +8%	142 672 +9%	151 135 +6%
Operating Income
Operating Expenses	(4 671)	(4 957)	(4 780)	(5 109)	(4 673)	(5 170)	(5 330)	(6 072)	(7 227)	(6 597)	(6 233)	(5 194)	(4 478)	(4 235)	(4 533)	(5 005)	(4 601)	(4 348)	(3 600)	(5 118)	(10 109)	(14 518)	(19 018)	(21 193)	(20 179)	(20 708)	(22 153)	(23 587)	(25 557)	(25 485)	(26 122)	(25 988)	(26 722)	(26 907)	(26 394)	(26 822)	(28 080)	(28 279)	(31 670)	(35 386)	(34 900)	(37 100)	(38 388)	(38 558)	(41 517)	(41 589)	(42 248)	(42 084)	(44 903)	(45 111)	(45 881)	(47 400)	(49 615)	(48 597)	(45 584)	(43 293)	(37 020)	(38 599)	(45 361)	(47 203)	(47 731)	(50 488)	(49 229)	(49 044)	(49 535)	(52 190)	(57 433)	(62 784)	(71 455)	(73 962)	(75 893)	(79 402)	(74 604)	(75 432)	(78 151)	(80 541)	(83 639)	(88 175)	(87 420)	(85 031)	(84 788)	(87 195)	(92 298)	(98 300)
Selling, General & Administrative	(4 015)	(4 312)	(4 160)	(4 515)	(4 101)	(4 562)	(4 665)	(5 342)	(6 451)	(5 831)	(5 501)	(4 486)	(3 788)	(3 632)	(3 906)	(4 390)	(4 079)	(3 854)	(3 240)	(4 618)	(9 235)	(13 628)	(18 317)	(20 631)	(19 509)	(20 347)	(20 962)	(21 972)	(22 879)	(24 201)	(24 591)	(24 629)	(24 132)	(25 006)	(24 968)	(25 145)	(25 826)	(26 056)	(29 416)	(33 449)	(33 728)	(35 919)	(37 097)	(36 829)	(39 156)	(38 896)	(39 467)	(39 587)	(42 434)	(42 876)	(43 797)	(45 361)	(47 331)	(45 900)	(42 505)	(39 866)	(33 781)	(35 320)	(38 002)	(39 385)	(43 942)	(46 359)	(44 649)	(44 666)	(43 453)	(45 172)	(50 550)	(55 346)	(64 083)	(67 181)	(68 293)	(70 679)	(65 487)	(65 569)	(67 512)	(66 975)	(68 182)	(68 142)	(66 200)	(66 056)	(68 089)	(70 385)	(75 329)	(79 188)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(412)	(2 264)	0	0	(1 038)	(1 893)	(1 567)	(1 861)	(1 446)	(788)	(804)	(821)	(1 079)	(1 489)	(1 585)	(1 538)	(1 230)	(1 204)	(987)	(851)	(787)	(1 033)	(1 427)	(1 791)	(2 126)	(1 919)	(1 883)	(1 907)	(2 266)	(2 132)	(2 156)	(2 593)	(2 490)	(4 612)	(5 730)	(5 753)	(6 389)	(6 365)	(5 743)	(6 551)	(7 635)	(7 999)	(8 723)	(9 089)	(11 413)	(12 707)	(13 971)	(14 818)	(12 624)	(13 045)	(13 104)	(13 051)	(14 718)
Depreciation & Amortization	(656)	(646)	(620)	(594)	(572)	(606)	(665)	(730)	(776)	(766)	(732)	(709)	(689)	(605)	(628)	(615)	(523)	(493)	(359)	(498)	(874)	(902)	(857)	(566)	(781)	(532)	(989)	(1 884)	(2 678)	(2 198)	(2 566)	0	(326)	(1 114)	0	0	(361)	(296)	(394)	(491)	(383)	(376)	(467)	(649)	(872)	(1 107)	(1 243)	(1 266)	(1 266)	(1 249)	(1 235)	(1 253)	(1 251)	(1 270)	(1 287)	(1 300)	(1 320)	(1 395)	(1 464)	(1 565)	(1 657)	(1 668)	(1 682)	(1 583)	(1 470)	(1 287)	(1 129)	(1 049)	(1 007)	(1 038)	(1 049)	(1 089)	(1 118)	(1 141)	(1 550)	(2 153)	(2 750)	(3 395)	(3 735)	(3 683)	(3 654)	(3 707)	(3 918)	(4 393)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14	156	4	110	171	(202)	269	0	914	1 035	(947)	0	(787)	(1 426)	(639)	0	(360)	0	0	0	0	(3)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(3 988)	(3 987)	0	(305)	(305)	(305)	0	0	0	0	0	0	0	0	0	0	0	0	0	(2 667)	(2 667)	(2 667)	0	0	0	0
Operating Income	1 908 N/A	2 204 +16%	2 760 +25%	3 425 +24%	4 326 +26%	4 645 +7%	4 525 -3%	3 515 -22%	4 113 +17%	4 242 +3%	4 194 -1%	3 969 -5%	2 139 -46%	468 -78%	(1 480) N/A	(3 223) -118%	(3 731) -16%	(3 909) -5%	(3 333) +15%	(1 160) +65%	(163) +86%	1 311 N/A	3 168 +142%	4 329 +37%	8 130 +88%	8 148 +0%	7 684 -6%	6 538 -15%	6 114 -6%	6 010 -2%	6 064 +1%	6 831 +13%	5 079 -26%	7 201 +42%	8 151 +13%	8 717 +7%	7 493 -14%	6 316 -16%	6 540 +4%	6 982 +7%	8 350 +20%	9 369 +12%	8 861 -5%	7 985 -10%	6 374 -20%	6 732 +6%	6 894 +2%	7 414 +8%	7 269 -2%	4 157 -43%	7 162 +72%	8 518 +19%	8 671 +2%	11 055 +27%	5 848 -47%	235 -96%	3 569 +1 419%	3 991 +12%	3 904 -2%	10 114 +159%	14 736 +46%	16 987 +15%	19 092 +12%	20 948 +10%	23 630 +13%	28 883 +22%	39 764 +38%	46 919 +18%	47 798 +2%	45 919 -4%	40 149 -13%	40 609 +1%	38 170 -6%	39 964 +5%	43 880 +10%	36 967 -16%	36 071 -2%	27 538 -24%	22 182 -19%	29 277 +32%	37 223 +27%	44 270 +19%	50 374 +14%	52 835 +5%
Pre-Tax Income
Interest Income Expense	(482)	(589)	(490)	(499)	(5)	336	480	849	1 019	951	1 294	1 420	245	822	704	280	(1 240)	(1 545)	(1 223)	(1 521)	(1 905)	(2 359)	(2 510)	(2 462)	(244)	(408)	(1 237)	(1 084)	(3 481)	(2 415)	(3 319)	(3 715)	15	(2 108)	(3 023)	(2 676)	(3 637)	(3 426)	(2 010)	(2 771)	(3 036)	(2 659)	(3 411)	(3 782)	(5 239)	(6 970)	(6 720)	(6 858)	(6 585)	(5 597)	(5 844)	(5 914)	(5 320)	(5 573)	(5 575)	(5 717)	(5 499)	(5 531)	(5 255)	(4 990)	(5 089)	(4 722)	(4 438)	(3 998)	(3 538)	(3 775)	(3 682)	(4 331)	(5 180)	(5 489)	(6 714)	(7 620)	(6 464)	(6 642)	(6 589)	(6 109)	(7 353)	(7 291)	(7 016)	(6 672)	(6 651)	(6 170)	(5 349)	(4 682)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(13)	0	0	(210)	(74)	0	0	0	0	0	0	0	0	0	0	(274)	99	99	99	373	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(3 902)	(3 987)	0	0	(306)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(2 667)	0	0	0	0	0	0	0
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	(2)	(5)	0	(5)	(33)	(43)	0	(43)	191	0	0	0	0	0	0	0	13	0	0	0	7	0	0	0	(142)	0	0	1	1	0	4	(46)	(42)	0	0	0	0	0	0	0	0	(3)	54	0	(3)	(199)	(251)	(374)	(459)	0	0	(7)	(26)	0	0	(18)	(0)	(0)	(0)	0	0	0	442	0	441	460	12	12	12	(56)	(65)	(88)
Total Other Income	181	250	287	323	193	130	120	113	(220)	(255)	(1 019)	(1 249)	(5 300)	(6 205)	(5 535)	(5 075)	564	519	1 038	829	570	905	407	404	0	1	1	1	883	30	(39)	(130)	(1 718)	(1 691)	(1 541)	(1 508)	182	18	3	116	222	161	73	6	(33)	(49)	(28)	53	(112)	(82)	(201)	(275)	(887)	(904)	(867)	(790)	(424)	(556)	(580)	(429)	(37)	(125)	11	37	62	44	(93)	(66)	(95)	(1 141)	(1 063)	(1 229)	(1 237)	(244)	(207)	234	(283)	(234)	(309)	(180)	(825)	(801)	(699)	(738)
Pre-Tax Income	1 607 N/A	1 866 +16%	2 557 +37%	3 249 +27%	4 515 +39%	5 109 +13%	5 124 +0%	4 476 -13%	4 911 +10%	4 939 +1%	4 469 -10%	4 140 -7%	(2 919) N/A	(4 920) -69%	(6 311) -28%	(8 024) -27%	(4 441) +45%	(4 978) -12%	(3 518) +29%	(1 893) +46%	(1 307) +31%	(156) +88%	1 065 N/A	2 271 +113%	7 676 +238%	7 667 0%	6 448 -16%	5 455 -15%	3 529 -35%	3 625 +3%	2 706 -25%	2 986 +10%	3 383 +13%	3 400 +1%	3 585 +5%	4 531 +26%	3 622 -20%	3 007 -17%	4 632 +54%	4 429 -4%	5 910 +33%	6 873 +16%	5 528 -20%	4 163 -25%	1 060 -75%	(287) N/A	146 N/A	609 +317%	572 -6%	(1 523) N/A	1 116 N/A	2 328 +109%	2 464 +6%	4 575 +86%	(540) N/A	(6 272) -1 061%	(6 260) +0%	(6 281) 0%	(2 181) +65%	4 321 N/A	8 845 +105%	12 140 +37%	14 665 +21%	16 980 +16%	20 128 +19%	25 152 +25%	35 989 +43%	42 503 +18%	42 522 +0%	39 289 -8%	32 372 -18%	31 760 -2%	30 469 -4%	33 078 +9%	37 526 +13%	31 093 -17%	26 209 -16%	20 473 -22%	14 869 -27%	22 437 +51%	29 759 +33%	37 243 +25%	44 261 +19%	47 327 +7%
Net Income
Tax Provision	(68)	(79)	(163)	(350)	(657)	(749)	(753)	(697)	(678)	(873)	(385)	(254)	(905)	208	(74)	(18)	(117)	24	429	1 585	2 614	2 728	1 562	139	(2 010)	(1 968)	(1 661)	(852)	(95)	(1 023)	832	556	169	1 045	(292)	(803)	(1 009)	(1 109)	(273)	(556)	(40)	(298)	(1 261)	(196)	5 674	7 280	6 750	6 668	2 344	1 458	1 973	1 349	251	165	(574)	(469)	(3 129)	(3 273)	(2 829)	(3 477)	(243)	(1 595)	(2 221)	(2 576)	812	873	(621)	(2 216)	(7 944)	(7 753)	(6 528)	(6 894)	(4 509)	(4 698)	(6 129)	(4 344)	(4 944)	(4 008)	(3 376)	(5 968)	(7 793)	(9 846)	(11 367)	(11 253)
Income from Continuing Operations	1 539	1 787	2 393	2 899	3 858	4 361	4 371	3 779	4 233	4 066	4 085	3 886	(3 824)	(4 712)	(6 385)	(8 041)	(4 558)	(4 953)	(3 088)	(308)	1 307	2 571	2 626	2 410	5 666	5 699	4 787	4 602	3 434	2 601	3 537	3 542	3 552	4 447	3 295	3 729	2 613	1 898	4 359	3 873	5 869	6 576	4 267	3 967	6 734	6 992	6 896	7 277	2 916	(65)	3 089	3 677	2 715	4 740	(1 114)	(6 741)	(9 389)	(9 554)	(5 010)	844	8 602	10 545	12 444	14 404	20 940	26 025	35 368	40 287	34 579	31 537	25 844	24 867	25 960	28 380	31 397	26 748	21 265	16 465	11 494	16 470	21 966	27 397	32 894	36 074
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	1 539 N/A	1 787 +16%	2 393 +34%	2 899 +21%	3 858 +33%	4 361 +13%	4 371 +0%	3 779 -14%	4 232 +12%	4 065 -4%	4 084 +0%	3 885 -5%	(3 824) N/A	(4 712) -23%	(6 385) -36%	(8 041) -26%	(4 558) +43%	(4 953) -9%	(3 088) +38%	(308) +90%	1 307 N/A	2 571 +97%	2 626 +2%	2 410 -8%	5 666 +135%	5 699 +1%	4 787 -16%	4 602 -4%	3 434 -25%	2 601 -24%	3 537 +36%	3 542 +0%	3 552 +0%	4 447 +25%	3 295 -26%	3 729 +13%	2 613 -30%	1 898 -27%	4 359 +130%	3 873 -11%	5 869 +52%	6 576 +12%	4 267 -35%	3 967 -7%	6 734 +70%	6 992 +4%	6 896 -1%	7 277 +6%	2 916 -60%	(65) N/A	3 089 N/A	3 677 +19%	2 715 -26%	4 740 +75%	(1 114) N/A	(6 741) -505%	(9 389) -39%	(9 554) -2%	(5 010) +48%	844 N/A	8 602 +919%	10 545 +23%	12 444 +18%	14 404 +16%	20 940 +45%	26 025 +24%	35 368 +36%	40 287 +14%	34 579 -14%	31 537 -9%	25 844 -18%	24 867 -4%	25 960 +4%	28 380 +9%	31 397 +11%	26 748 -15%	21 265 -20%	16 465 -23%	11 494 -30%	16 470 +43%	21 966 +33%	27 397 +25%	32 894 +20%	36 074 +10%
EPS (Diluted)	320.19 N/A	421.44 +32%	555.37 +32%	638.2 +15%	871.75 +37%	714.09 -18%	667.08 -7%	616.73 -8%	684.03 +11%	672.27 -2%	675.42 +0%	665.53 -1%	-496.16 N/A	-475.41 +4%	-645.34 -36%	-755.33 -17%	-468.53 +38%	-519.25 -11%	-312.89 +40%	-21.41 +93%	100.11 N/A	140.41 +40%	142.78 +2%	130.42 -9%	285.14 +119%	254.66 -11%	258.16 +1%	248.18 -4%	153.45 -38%	116.22 -24%	187.21 +61%	184.19 -2%	185.61 +1%	208.48 +12%	154.48 -26%	173.09 +12%	87.08 -50%	88.98 +2%	136.26 +53%	123.2 -10%	266.82 +117%	154.57 -42%	156.77 +1%	132.39 -16%	223.98 +69%	199.16 -11%	179.8 -10%	182.71 +2%	78.73 -57%	-1.54 N/A	69.97 N/A	83.27 +19%	61.45 -26%	106.6 +73%	-25.13 N/A	-152.11 -505%	-211.88 -39%	-214.93 -1%	-112.71 +48%	19.02 N/A	193.32 +916%	226.42 +17%	279.05 +23%	323.57 +16%	469.81 +45%	582.68 +24%	793.24 +36%	903.26 +14%	779.49 -14%	708.04 -9%	581.27 -18%	559.18 -4%	583.86 +4%	638.66 +9%	707.18 +11%	602.41 -15%	478.89 -21%	370.54 -23%	259 -30%	371.17 +43%	494.86 +33%	617.8 +25%	742.67 +20%	814.26 +10%

Income Statement Balance Sheet Cash Flow Statement

Celltrion Pharm Inc
KOSDAQ:068760

Income Statement

Earnings Waterfall
Celltrion Pharm Inc

Income Statement
Celltrion Pharm Inc

See Also

Company

Help

Tools

Stocks

Celltrion Pharm Inc KOSDAQ:068760

Income Statement

Earnings Waterfall Celltrion Pharm Inc

Income Statement Celltrion Pharm Inc

See Also

Company

Help

Tools

Stocks

Celltrion Pharm Inc
KOSDAQ:068760

Earnings Waterfall
Celltrion Pharm Inc

Income Statement
Celltrion Pharm Inc